Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Mirunalini, S.
- Therapeutic Efficacy of Phyllanthus emblica L. Fruit Extract and Cisplatin Combination against 7, 12-Dimethylbenz(a)Anthracene Induced Hamster Buccal Pouch Carcinogenesis
Abstract Views :453 |
PDF Views:402
Authors
Affiliations
1 Annamalai University, Annamalainagar – 608 002, Tamil Nadu, IN
1 Annamalai University, Annamalainagar – 608 002, Tamil Nadu, IN
Source
FoodSci: Indian Journal of Research in Food Science and Nutrition, Vol 3, No 1 (2016), Pagination: 1-9Abstract
Amla fruit has been conventionally used as a health food for the prevention and therapy of cancer. Accordingly, the study aimed to explore the chemotherapeutic efficacy of amla and cisplatin combination on molecular mechanistic apoptosis implicated in proliferation, apoptosis and angiogenesis moleules during DMBA-induced buccal pouch carcinogenesis. Our western blot results showed that up regulation of Bcl-2, cyclin D1, Proliferating cell nuclear antigen, Cdc25C, Cox-2, Vascular endothelial growth factor and Survivin were observed in DMBA treated groups, whereas after treatment with combination therapy significantly down regulated the above noted proteins expression level. It was also observed that combination of amla and cisplatin treated tumor groups induced increased levels of Bax, caspase-3 and caspase-9 levels. More intriguingly, the effect was more pronounced in the tumor animals receiving combination therapy suggesting a synergistic effect. The results clearly suggest that combination therapy of amla and cisplatin had inhibitory effect during oral carcinogenesis via induction of apoptosis and suppression of molecules involved in cell proliferation and angiogenesis. Thus, amla fruit contains novel rich source of natural antioxidants and can be considered as an adjuvant therapeutic agent with cisplatin for oral cancer.Keywords
Angiogenesis, Apoptosis, Buccal Pouch Cancer, Chemotherapy, Phyllanthus emblica, Proliferation.Full Text
References
- Ko Y. C., Huang Y. L., Lee C. H., Chen M. J., Lin L. M., and Tsai C. C., “Betel quid a chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan”, J Oral Pathol Med, vol. 24, p. 450–453, 1995.
- Meijer C., Van Luyn M. J., Nienhuis E. F., Blom N., Mulder N. H., and De Vries E. G., “Ultrastructural morphology and localization of cisplatin-induced platinum–DNA adducts in a cisplatin-sensitive and-resistant human small cell lung cancer cell line using electron microscopy”, Biochem Pharmacol, vol. 61, p. 573–578, 2001.
- Singh B. N., Fu J., Srivastava R. K., and Shankar S., “Hedgehog signaling antagonist GDC-(Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms”, PLoS One, vol. 6, e27306, 2011.
- Wang D., and Lippard S. J., “Cellular processing of platinum anticancer drugs”, Nat Rev Drug Disc, vol. 4, p. 307–320, 2005.
- Zhang Y., Wang C., Wang H., Wang K., Du Y., and Zhang J., “Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo”, Cancer Lett, vol. 304, p. 21–32, 2011.
- Zygogianni A. G., Kyrgias G., Karakitsos P., Psyrri A., Kouvaris J., and Kelekis N., “Oral squamous cell cancer: early detection and the role of alcohol and smoking”, Head Neck Oncol, vol. 3, p. 2, 2011.